Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 2 (2012) 1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW Abstract  similar documents
R. R. Mamatkazina, I. P. Kolos, S. E. Serdyuk, E. P. Mazygula, A. V. Sveshnikov
"... ablation (RFA) is the most justified treatment method in patients with WPW-syndrome and "malignant" Kent’s ..."
 
Vol 14, No 5 (2018) Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation Abstract  similar documents
M. H. Fedorova, V. L. Doshchitsin, A. V. Chapurnykh
"... ) and radiofrequency ablation (RFA) of elderly and senile pa- tients with relapsing atrial fibrillation (AF) as more ..."
 
Vol 19, No 2 (2023) Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease Abstract  similar documents
D. A. Tsaregorodtsev, M. A. Khalikova, S. S. Vasyukov, M. M. Beraya, A. V. Sedov
"... within 6 and 12 months from the onset of antiarrhythmic drug therapyand in RFA and CRYO groups – within 6 ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION Abstract  similar documents
Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev
"... Modern approaches to antiarrhythmic anti-relapse therapy of atrial fibrillation are considered ..."
 
Vol 7, No 1 (2011) ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
"... Aim. To assess propafenone antiarrhythmic efficacy and optimal timing of the drug administration ..."
 
Vol 7, No 3 (2011) PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
V. A. Sulimov, A. S. Lishuta
"... Basic principles of the management of patients with atrial fibrillation (AF) are discussed taking ..."
 
Vol 15, No 1 (2019) Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality? Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... of mutations associated with atrial fibrillation (AF). The novel methods enable us to study histological ..."
 
Vol 5, No 1 (2009) CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY Abstract  similar documents
Yu. A. Bunin
"... Data on atrial fibrillation (AF) epidemiology and AF influence on the risk of cardiovascular ..."
 
Vol 3, No 4 (2007) PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY Abstract  similar documents
B. A. Tatarskii
"... used to terminate of atrial fibrillation are given. The choice of antiarrhythmic drug is considerate ..."
 
Vol 11, No 4 (2015) CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. Z. Loriya
"... atrial fibrillation (AF) treated with various antiarrhythmic drugs. Material and methods. Patients ..."
 
Vol 3, No 5 (2007) EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
"... of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF). Material and methods ..."
 
Vol 16, No 5 (2020) Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation Abstract  similar documents
E. P. Popova, S. S. Puzin, O. T. Bogova, S. N. Puzin, D. A. Sychev, V. P. Fisenko
"... Aim. To study the effect of class III antiarrhythmic drugs (amiodarone and sotalol), and the β ..."
 
Vol 17, No 5 (2021) Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan
"... (mean age 43.1±11.3 years, 10 female) with atrial fibrillation (AF), supraventricular and ventricular ..."
 
Vol 17, No 2 (2021) Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness Abstract  similar documents
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
"... Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon ..."
 
Vol 17, No 5 (2021) Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety Abstract  similar documents
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
"... Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon ..."
 
Vol 21, No 2 (2025) Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion Abstract  similar documents
Kh. M. Dzaurova, N. Yu. Mironov, Yu. A. Yuricheva, M. M. Belyaeva, S. F. Sokolov, N. A. Mironova, S. P. Golitsyn, O. Yu. Korennova, I. M. Zueva, E. A. Turusheva, D. S. Terekhov
"... of unsuccessful cardioversion to terminate current persistent and paroxysmal atrial fibrillation (AF) episode ..."
 
Vol 19, No 1 (2023) Relief of persistent atypical atrial flutter: experience with the use of niferidil Abstract  similar documents
E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar
"...   in the population.  Fibrillation and atrial flutter are among  the most common  causes  of a decrease ..."
 
Vol 7, No 6 (2011) NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina
"... The main objectives and strategies for treatment of atrial fibrillation (AF), one of the most ..."
 
Vol 13, No 6 (2017) ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY Abstract  similar documents
Yu. А. Bunin, S. V. Miklishanskaya
"... Atrial fibrillation (AF), being both a cause and a consequence of chronic heart failure (CHF ..."
 
Vol 13, No 1 (2017) COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY Abstract  similar documents
A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich
"... . Aim. To study the effectiveness of antiarrhythmic drugs: propafenone, sotalol and verapamil ..."
 
Vol 13, No 4 (2017) ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, E. V. Kokhan, G. K. Kiyakbaev, A. A. Shavarov
"... and prognostic value of atrial fibrillation (AF). Left atrial structural and functional changes associated ..."
 
Vol 17, No 2 (2021) Rotor Drivers in Induction and Maintenance of Atrial Fibrillation Abstract  similar documents
A. A. Kulikov, O. V. Sapelnikov, T. M. Uskach, D. I. Cherkashin, I. R. Grishin, R. S. Akchurin
"... Atrial fibrillation is the most common arrhythmia in clinical practice. It is associated ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..."
 
Vol 9, No 1 (2013) THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS Abstract  similar documents
A. O. Malygin, V. L. Doshchitsin
"... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..."
 
Vol 17, No 3 (2021) An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus Abstract  similar documents
V. N. Larina, O. Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, T. Yu. Demidova
"... Atrial fibrillation (AF) is a complex pathology that requires an integrated approach in both ..."
 
Vol 16, No 5 (2020) Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation Abstract  similar documents
M. G. Bubnova, D. M. Aronov
"... activity and risk of atrial fibrillation (AF) development and the impact of cardiac rehabilitation programs ..."
 
Vol 13, No 5 (2017) POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME Abstract  similar documents
G. V. Matyushin, S. Yu. Nikulina, A. A. Chernova, I. I. Lebedeva, A. A. Semenchukov
"... in predicting and diagnosing latent forms of the disease. Wolff-Parkinson-White syndrome (WPW) occurs in all age ..."
 
Vol 9, No 6 (2013) DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
"... of antiarrhythmic drugs may be regarded as one of the myths of modern cardiology. Multiple references to negative ..."
 
Vol 14, No 5 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness Abstract  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... Aim. We aimed to compare effectiveness of new  class III antiarrhythmic drug  Refralon with direct ..."
 
Vol 14, No 6 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety Abstract  PDF (Eng)  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current ..."
 
Vol 14, No 4 (2018) Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment Abstract  similar documents
Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova
"... Atrial fibrillation (AF) is the most common tachyarrhythmia complicating ST segment elevation ..."
 
Vol 18, No 3 (2022) Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice Abstract  similar documents
V. L. Doshchitsin, A. I. Tarzimanova
"... the second half of the 20th century, when new antiarrhythmic drugs began to be used in clinical practice ..."
 
Vol 16, No 3 (2020) The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... of ω-3 PUFA can be considered their anti-atherogenic effect. Antiarrhythmic properties of го-3 PUFA ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... Use of class I antiarrhythmic drugs in the elderly is limited by their adverse drug reactions (ADRs ..."
 
Vol 12, No 5 (2016) Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... The effectiveness of antiarrhythmic drugs in the elderly is similar to that in younger patients ..."
 
Vol 6, No 6 (2010) THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS Abstract  similar documents
Yu. A. Bunin
 
Vol 11, No 3 (2015) ALCOHOL AND HEART RHYTHM DISORDERS Abstract  similar documents
A. O. Yusupova, A. S. Lishuta
"... complications among other cardiac arrhythmias should use both antiarrhythmic and anti-alcohol drugs ..."
 
Vol 18, No 2 (2022) Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases Abstract  similar documents
A. N. Zakirova, N. E. Zakirova
"... antiarrhythmic effects, improving endothelial function, showing an anti- inflammatory effect, affecting ..."
 
Vol 19, No 3 (2023) Ventricular tachycardia and myocardial infarction during antiarrhythmic therapy: a case report Abstract  similar documents
A. A. Gurbanova, K. G. Pereverzeva, S. S. Yakushin, I. V. Budanova
"... failure. In 2020, the patient was diagnosed with ventricular extrasystole and started antiarrhythmic ..."
 
Vol 19, No 6 (2023) Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors Abstract  similar documents
L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev
"... Aim. To identify predictors of paroxysmal atrial fibrillation (pAF) in patients with stable angina ..."
 
Vol 9, No 4 (2013) ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION Abstract  similar documents
O. M. Drapkina, A. V. Emelyanov
"... Mechanisms of atrial fibrosis including the role of serotonin in the development of this lesion ..."
 
Vol 17, No 6 (2021) Drug-Induced Atrial Fibrillation / Atrial Flutter Abstract  similar documents
O. D Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, A. E. Vorobieva, D. I. Bakhteeva, S. P. Korchagina, O. V. Bondarets, N. D. Boyko, D. A. Sychev
"... Drug-induced atrial fibrillation / flutter (DIAF) is a serious and potentially life-threatening ..."
 
Vol 19, No 1 (2023) Atrial Fibrillation: a Marker or Risk Factor for Stroke Abstract  similar documents
B. A. Tatarsky, D. A. Napalkov
"... Atrial fibrillation (AF) is strongly associated with stroke risk, but an association by itself ..."
 
Vol 12, No 3 (2016) GENETIC PREDICTORS OF ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
"... Atrial fibrillation (AF) is the most common heart rhythm disturbance. It is believed ..."
 
Vol 13, No 3 (2017) HYPERTHYROIDISM AND ATRIAL FIBRILLATION Abstract  similar documents
I. M. Marusenko, E. G. Petrova
"... Review on a problem of the development of atrial fibrillation in patients with thyrotoxicosis ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial ..."
 
Vol 7, No 1 (2011) ATRIAL FLUTTER: CONTEMPORARY POSSIBILITIES OF DIAGNOSIS AND TREATMENT Abstract  similar documents
Yu. A. Bunin
"... Diagnosis and treatment of atrial flutter (AF) is an important clinical task. Epidemiological data ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use ..."
 
Vol 11, No 6 (2015) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use ..."
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent ..."
 
Vol 11, No 2 (2015) ALCOHOL-INDUCED CARDIAC RHYTHM DISORDERS IN PATIENTS WITH ALCOHOL DEPENDENCE: TYPES OF ARRHYTHMIAS, MECHANISMS OF ORIGIN, PARTICULARITIES OF COURSE AND ANTIARRHYTHMIC THERAPY Abstract  similar documents
A. S. Aksel'rod, A. L. Syrkin
"... in constant antiarrhythmic therapy within 36 months after the alcohol cessation, and patients with paroxysmal ..."
 
Vol 15, No 1 (2019) Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy Abstract  similar documents
Yu. A. Bunin, S. A. Miklishanskaya, E. A. Zolozova, V. V. Chigineva
"... The article is devoted to the description of all types of atrial tachyarrhythmias, including ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... patients with paroxysmal atrial fibrillation (AF) in the longterm follow-up. Material and methods ..."
 
Vol 12, No 5 (2016) Pathogenic Mechanisms of Atrial Fibrillation in Obesity Abstract  similar documents
O. M. Drapkina, M. V. Nikolaeva
"... Atrial fibrillation (AF) is one of the most common arrhythmias. It reduces quality of life and its ..."
 
Vol 4, No 2 (2008) CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION Abstract  similar documents
S. Y. Nikulina, V. A. Schulman, O. O. Kuznetsova, N. V. Aksjutina, P. A. Shesternja, A. A. Chernova, V. N. Maksimov, I. V. Kulikov, S. N. Ustinov, Y. L. Kazarinova, A. G. Romashchenko, M. I. Voevoda
"... Aim. To study inheritance patterns of atrial fibrillation (AF) and association of primary ..."
 
Vol 15, No 2 (2019) Current Predictors of Atrial Fibrillation Progression Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Aim. To identify predictors of progression of atrial fibrillation (AF) in patients ..."
 
Vol 17, No 3 (2021) Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension Abstract  similar documents
E. V. Kokhan, G. K. Kiyakbaev, E. M. Ozova, V. A. Romanova, Zh. D. Kobalava
"... Aim. To study the impact of heart rate (HR) reduction with beta-blockers (BB) on left atrial (LA ..."
 
Vol 10, No 2 (2014) CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... (IHD) and paroxysmal atrial fibrillation (AF) during treatment with amiodarone 200 mg daily compared ..."
 
Vol 10, No 3 (2014) THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE Abstract  similar documents
K. V. Davtyan, O. N. Tkacheva, A. A. Kalemberg, S. N. Koretsky
"... Some aspects of prevention of thromboembolic events in patients with atrial fibrillation ..."
 
Vol 15, No 5 (2019) Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure Abstract  similar documents
E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava
"... Aim. To evaluate gender-related differences of left atrial (LA) phasic function and structural ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... New data and perspectives of antithrombotic therapy are highlighted in patients with atrial ..."
 
Vol 7, No 2 (2011) PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE Abstract  similar documents
I. V. Graifer, O. V. Reshet'ko, N. V. Furman
"... Aim. To analyze current clinical practice in the treatment of atrial fibrillation (AF ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... and international normalized ratio (INR) control for patients with atrial fibrillation (AF) per 1 year of treatment ..."
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..."
 
Vol 16, No 4 (2020) Telocytes and Atrial Fibrillation: From Basic Research to Clinical Practice Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, A. S. Frolova
"... , and molecular causes of atrial fibrillation (AF). Recently, the role of interstitial telocyte cells ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... The possibilities of antithrombotic therapy in atrial fibrillation are highlighted ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed ..."
 
Vol 8, No 5 (2012) POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov
"... Aim. To identify possible predictors of atrial fibrillation (AF) recurrence in 6-month ..."
 
Vol 14, No 3 (2018) CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... of the endothelium, and appearance of new cases of atrial fibrillation (AF) in patients with arterial hypertension ..."
 
Vol 16, No 5 (2020) Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov
"... Aim. To study the changes that have occurred in the pharmacotherapy of atrial fibrillation (AF ..."
 
Vol 17, No 1 (2021) Asymptomatic Supraventricular Arrhythmias in Patients Undergoing Dialysis Abstract  similar documents
O. V. Likhachev-Mishchenko, A. A. Kornienko, N. A. Kornienko, L. A. Khaisheva, A. A. Dyuzhikov, S. V. Shlyk
"... a higher risk of nonfatal cardiovascular events (HR 4.32; 95%CI 2.11-8.83) and symptomatic atrial ..."
 
Vol 15, No 5 (2019) Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... and their combinations on the survival of patients with atrial fibrillation (AF) in the REKUR-AF study. Material ..."
 
Vol 17, No 6 (2021) Atrial Fibrillation in Cancer Patients: Who is at Risk? Abstract  similar documents
Yu. A. Vasyuk, E. Yu. Shupenina, D. A. Vyzhigin, E. O. Novosel, K. V. Gallinger
"...   to reduce  the effectiveness  of cancer  patient’s  treatment.  Atrial  fibrillation  is frequent ..."
 
Vol 19, No 5 (2023) Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) Abstract  similar documents
V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina
"... cardiovascular events) in outpatients with atrial fibrillation (AF) in one of the Yaroslavl clinics for 10 years ..."
 
Vol 13, No 5 (2017) LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE Abstract  similar documents
E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin
"... Assessment of the left atrial (LA) function is important aspect of comprehensive cardiovascular ..."
 
Vol 19, No 2 (2023) Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? Abstract  similar documents
I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva
"... Aim. To compare different scores in assessment of risk of left atrial or its appendage thrombosis ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... and systemic embolic events in more than 18000 patients with nonvalvular atrial fibrillation. At that time ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... Current guidelines for the management of atrial fibrillation (AF) recommend using anticoagulants ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... Advanced age is the most important and independent risk factor for the development of atrial ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... associated with nonvalvular atrial fibrillation, particularly ischemic stroke. Confirmation of the efficacy ..."
 
Vol 11, No 1 (2015) ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS Abstract  similar documents
R. Bhattarai, S. A. Sayganov, E. V. Trofimova
"... Aim. To specify the mechanism of atrial fibrillation (AF) development and to evaluate the function ..."
 
Vol 16, No 1 (2020) Atrial Fibrillation: Development Mechanisms, Approaches and Prospects of Therapy Abstract  similar documents
O. V. Sapelnikov, A. A. Kulikov, D. I. Cherkashin, I. R. Grishin, O. A. Nikolaeva, R. S. Akchurin
"... Atrial fibrillation (AF) is the most common arrhythmia. It is diagnosed in more than 33 million ..."
 
Vol 16, No 2 (2020) Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation Abstract  similar documents
Yu. P. Skirdenko, N. A. Nikolaev
"... of complications of atrial fibrillation (AF). Material and methods. Patients with AF (n=98) were included ..."
 
Vol 10, No 3 (2014) ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
E. I. Leonova, G. G. Shehan, V. S. Zadionchenko, K. M. Bogatyrova
"... Characteristics of atrial fibrillation pathogenesis in patients with chronic obstructive pulmonary ..."
 
Vol 17, No 2 (2021) Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage Abstract  similar documents
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov
"... with an incidence 0.3-0.7% per year. For patients with atrial fibrillation (AF) anticoagulants are administered ..."
 
Vol 17, No 2 (2021) Laboratory predictors of clinical outcomes in patients with atrial fibrillation Abstract  similar documents
A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov
"... Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice that affects ..."
 
Vol 15, No 1 (2019) Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary ..."
 
Vol 15, No 3 (2019) Genetic, Epigenetic and Transcription Factors in Atrial Fibrillation Abstract  similar documents
O. V. Sapelnikov, A. A. Kulikov, O. O. Favorova, N. A. Matveeva, D. I. Cherkashin, O. A. Nikolaeva, R. S. Akchurin
"... Atrial fibrillation (AF) is one of the most common arrhythmia that occurs in patients ..."
 
Vol 15, No 4 (2019) Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital Abstract  similar documents
O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova
"... Aim. To study detection of atrial septal aneurysm (ASA) by transthoracic echocardiography ..."
 
Vol 17, No 5 (2021) Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case Abstract  similar documents
A. A. Avagimyan, L. H. Mkrtchyan, A. A. Gevorkyan, N. B. Kononchuk, L. V. Kakturskiy, Z. T. Djndoyan
"... -related atrial fibrillation (AF) development in the young woman, elaborated as a result of multiple ..."
 
Vol 18, No 5 (2022) Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova
"... with atrial fibrillation. Direct oral anticoagulants have replaced vitamin K antagonists: either direct ..."
 
Vol 19, No 2 (2023) Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment Abstract  similar documents
O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva
"... Aim. To study the efficacy and safety of antithrombotic therapy in patients with paroxysmal atrial ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
"... in routine clinical practice in patients with non-valvular atrial fibrillation. In consecutive patients who ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... Atrial fibrillation (AF) is the most common cardiac cause of systemic embolism and cardioembolic ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... and apixaban in patients with non-valvular atrial fibrillation (AF) and to assess the impact of the both ..."
 
Vol 6, No 5 (2010) THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets
"... Aim. To study the effect of atorvastatin on the rate of atrial fibrillation (AF) recurrence after ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... atrial fibrillation is considered. Results of randomized clinical trials on efficacy and safety ..."
 
Vol 10, No 2 (2014) SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT Abstract  similar documents
E. A. Drozdova
"... Atrial fibrillation is one of the main risk factor of ischemic stroke. Current problems ..."
 
Vol 11, No 2 (2015) AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER Abstract  similar documents
V. V. Yakusevich, E. M. Pozdnyakova, Vl. .V. Yakusevich, V. A. Simonov, S. Yu. Martsevich, M. M. Loukianov, A. V. Zagrebelnyy, S. A. Boytsov
"... Aim. To study the clinical forms of atrial fibrillation (AF), cardiovascular risk factors ..."
 
1 - 100 of 362 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)